Pluripotent Stem Cell Applications for Regenerative Medicine

Overview

Journal Curr Opin Organ Transplant

Specialty General Surgery

Date 2015 Nov 5

PMID 26536430

Citations 23

Authors

Mathew G Angelos

Dan S Kaufman

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: In this review, we summarize the current status of clinical trials using therapeutic cells produced from human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs). We also discuss combined cell and gene therapy via correction of defined mutations in human pluripotent stem cells and provide commentary on key obstacles facing widescale clinical adoption of pluripotent stem cell-based therapy.

Recent Findings: Initial data suggest that hESC/hiPSC-derived cell products used for retinal repair and spinal cord injury are safe for human use. Early-stage studies for treatment of cardiac injury and diabetes are also in progress. However, there remain key concerns regarding the safety and efficacy of these cells that need to be addressed in additional well designed clinical trials. Advances using the clustered regulatory interspaced short palindromic repeats (CRISPR)/Cas9 gene-editing system offer an improved tool for more rapid and on-target gene correction of genetic diseases. Combined gene and cell therapy using human pluripotent stem cells may provide an additional curative approach for disabling or lethal genetic and degenerative diseases wherein there are currently limited therapeutic opportunities.

Summary: Human pluripotent stem cells are emerging as a promising tool to produce cells and tissues suitable for regenerative therapy for a variety of genetic and degenerative diseases.

Citing Articles

Extracellular derivatives for bone metabolism.

Wu Y, Song P, Wang M, Liu H, Jing Y, Su J J Adv Res. 2024; 66:329-347.

PMID: 38218580 PMC: 11674789. DOI: 10.1016/j.jare.2024.01.011.

CRISPR/Cas9 Mediated Therapeutic Approach in Huntington's Disease.

Alkanli S, Alkanli N, Ay A, Albeniz I Mol Neurobiol. 2022; 60(3):1486-1498.

PMID: 36482283 PMC: 9734918. DOI: 10.1007/s12035-022-03150-5.

Hepatocyte Growth Factor-Preconditioned Neural Progenitor Cells Attenuate Astrocyte Reactivity and Promote Neurite Outgrowth.

Hong J, Dragas R, Khazaei M, Ahuja C, Fehlings M Front Cell Neurosci. 2021; 15:741681.

PMID: 34955750 PMC: 8695970. DOI: 10.3389/fncel.2021.741681.

Cell augmentation strategies for cardiac stem cell therapies.

Cruz-Samperio R, Jordan M, Perriman A Stem Cells Transl Med. 2021; 10(6):855-866.

PMID: 33660953 PMC: 8133336. DOI: 10.1002/sctm.20-0489.

High-precision multiclass cell classification by supervised machine learning on lectin microarray data.

Shibata M, Okamura K, Yura K, Umezawa A Regen Ther. 2021; 15:195-201.

PMID: 33426219 PMC: 7770415. DOI: 10.1016/j.reth.2020.09.005.

References

Xie F, Ye L, Chang J, Beyer A, Wang J, Muench M . Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac. Genome Res. 2014; 24(9):1526-33. PMC: 4158758. DOI: 10.1101/gr.173427.114. View

Lee G, Papapetrou E, Kim H, Chambers S, Tomishima M, Fasano C . Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature. 2009; 461(7262):402-6. PMC: 2784695. DOI: 10.1038/nature08320. View

Schuetz C, Markmann J . Immunogenicity of β-cells for autologous transplantation in type 1 diabetes. Pharmacol Res. 2015; 98:60-8. DOI: 10.1016/j.phrs.2015.03.003. View

Levenstein M, Ludwig T, Xu R, Llanas R, Vandenheuvel-Kramer K, Manning D . Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells. 2005; 24(3):568-74. PMC: 4615709. DOI: 10.1634/stemcells.2005-0247. View

Cavazzana-Calvo M, Payen E, Negre O, Wang G, Hehir K, Fusil F . Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature. 2010; 467(7313):318-22. PMC: 3355472. DOI: 10.1038/nature09328. View

Ran F, Hsu P, Lin C, Gootenberg J, Konermann S, Trevino A . Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell. 2013; 154(6):1380-9. PMC: 3856256. DOI: 10.1016/j.cell.2013.08.021. View

Osborn M, Starker C, McElroy A, Webber B, Riddle M, Xia L . TALEN-based gene correction for epidermolysis bullosa. Mol Ther. 2013; 21(6):1151-9. PMC: 3677309. DOI: 10.1038/mt.2013.56. View

Ding Q, Regan S, Xia Y, Oostrom L, Cowan C, Musunuru K . Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell. 2013; 12(4):393-4. PMC: 3925309. DOI: 10.1016/j.stem.2013.03.006. View

Nakatsuji N, Nakajima F, Tokunaga K . HLA-haplotype banking and iPS cells. Nat Biotechnol. 2008; 26(7):739-40. DOI: 10.1038/nbt0708-739. View

10.

Piccart-Gebhart M, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I . Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005; 353(16):1659-72. DOI: 10.1056/NEJMoa052306. View

11.

Simonson O, Domogatskaya A, Volchkov P, Rodin S . The safety of human pluripotent stem cells in clinical treatment. Ann Med. 2015; 47(5):370-80. DOI: 10.3109/07853890.2015.1051579. View

12.

Isalan M . Zinc-finger nucleases: how to play two good hands. Nat Methods. 2011; 9(1):32-4. DOI: 10.1038/nmeth.1805. View

13.

Hanna J, Wernig M, Markoulaki S, Sun C, Meissner A, Cassady J . Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. 2007; 318(5858):1920-3. DOI: 10.1126/science.1152092. View

14.

Ebert A, Yu J, Rose Jr F, Mattis V, Lorson C, Thomson J . Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2008; 457(7227):277-80. PMC: 2659408. DOI: 10.1038/nature07677. View

15.

Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou A . Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med. 2004; 10(1):55-63. DOI: 10.1038/nm979. View

16.

. Move over ZFNs. Nat Biotechnol. 2011; 29(8):681-4. DOI: 10.1038/nbt.1935. View

17.

Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, Itskovitz-Eldor J . Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A. 2002; 99(15):9864-9. PMC: 125045. DOI: 10.1073/pnas.142298299. View

18.

Binder S, Stolba U, Krebs I, Kellner L, Jahn C, Feichtinger H . Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study. Am J Ophthalmol. 2002; 133(2):215-25. DOI: 10.1016/s0002-9394(01)01373-3. View

19.

Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V . Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391):1145-7. DOI: 10.1126/science.282.5391.1145. View

20.

Piganeau M, Ghezraoui H, De Cian A, Guittat L, Tomishima M, Perrouault L . Cancer translocations in human cells induced by zinc finger and TALE nucleases. Genome Res. 2013; 23(7):1182-93. PMC: 3698511. DOI: 10.1101/gr.147314.112. View